The Fast Money traders share their final trades of the day.» Read More
This year's best-performing stocks have the best-looking balance sheets, punctuating investors' diminished appetite for risk-taking in the wake of the credit and housing-market turmoil.
For some time now, the watchword in investing has been "value." As a result, some fund managers think, the prices of growth stocks have slid to bargain levels. Tom Ognar, portfolio manager of the four-star Wells Fargo Advantage Growth Fund, agrees.
Is alternative energy in your investing future?
Was the selloff in Citigroup shares overdone? The stock tanked 7 percent to a 4-year low--and lost more than than $16 billion in market value--after an analyst downgraded the nation's biggest bank, citing concerns about its capital needs.
Last month's gains -- 1.5 percent for the Standard & Poor's 500 and 5.8 percent for Nasdaq -- belie a trend of withering leadership, where a handful of technology shares are doing the heavy lifting while the rest of the market stalls or fades.
Historically November has been a better month for the markets than October, especially for the NASDAQ. As stocks finish on a positive note for the month of October, here is the historical performance for both months.
On Halloween, five-star fund manager Peter Klein sees some saints among the corporate hobgoblins. All of the Fifth Third Asset Management portfolio manager's stock selections have "issues," he concedes. But Klein sees fewer tricks and more treats ahead for these companies.
The World Wide Web has given a dramatic new meaning to the phrase "net profits." Just ask five-star fund manager Ryan Jacob, portfolio manager of Jacob Internet Fund. Read his five choices for an investor's Internet interests.
They're not the most exciting companies on the stock exchanges, and five-star trader Neil Hennessey says that may be just the point. The president and portfolio manager of Hennessy Funds offered up five overlooked stocks for CNBC's "5 For 5."
Even as much of the economy contracts, health care continues to grow, and investment opportunities continue to grow with it. What to choose among those investment opportunities? Analyst Michael Magiera of Manning & Napier looks past some of the more volatile pharmaceutical stocks.
Looking at the market, what does a big-market player see? Randall Eley, president and chief investment officer of the Edgar Lomax Co., and John Bollinger, president of Bollinger Capital Management, shared their insights -- and stock picks.
Steven Neimeth, portfolio manager of the SunAmerica Value Fund, sees plenty of positives in this turbulent market. The strategist offered CNBC his view of the economy -- and named the stocks he likes.
Even with the major-indexes in a seeming free-fall, there are ways for investors to make money. Experts Monday spoke with CNBC to discuss some smart strategies to employ in a difficult market.
Sprint Nextel shares fell almost 4 percent Tuesday a day after the No. 3 U.S. mobile-phone service warned it would not meet 2007 financial targets and said its chief executive had stepped down.
A sprinkling of deal news, sinking oil prices and a firmer dollar are in the background as stocks edge higher Tuesday. The big news for markets though will come in the Federal Reserve's meeting minutes, set for release at 2 p.m. ET. The minutes of the September 18 meeting and the August 16 call will be released. Traders are watching for hints of what made the Fed take the aggressive step to slash the Fed funds rate by a half point, greater than the 1/4 point widely expected.
The Fed and the start of earnings season are two big focuses for stocks Tuesday, after Monday's dullish session. The Fed releases minutes of its September 18 meeting and its August 16 call at 2p ET. This time last week, traders would have been digging into those minutes to find any confirmation of their view that rates will be cut again at the Fed's October 31 meeting.
Scott Richter, portfolio manager with Fifth Third Asset Management, oversees the Fifth Third Disciplined Large Cap Value Fund. The fund is up 8 percent year-to-date and 13 percent over the last three years. The strategist offered CNBC viewers and CNBC.com readers a few of his favorite stocks in the health care and biotechnology sector.
Coming soon — well, maybe not that soon — to a theater near you: The story of a depraved, drug-addicted stock swindler. And the story is true.
Belo said Monday it plans to spin off its newspapers -- which have been struggling to keep readers and advertising dollars -- into a new company that will operate separately from its 20 television stations.
October's normally the month to fear on Wall Street, but it'll be hard to top the scary volatility of the summer. A hefty economic calendar, the start of corporate earnings season, news from the mired housing market, and the continuing unwinding of the credit crunch will keep market volatility high this coming month.